BARINTHUS BIOTHERAPEUTICS PLC |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.03 USD | -0.98% |
|
-19.61% | -44.44% |
Chart calendar Barinthus Biotherapeutics plc
7b.QcyO_riRZXqloy__EQ6876NtmsqYwizSh0C8h3CAN-0.LofIqunVCQjfk2GxQ3fKgO4JzPPTsmrg6TPK1z3wQYQDvr3K3ugkCojLGw~e23115c0654f63389536561e31ea69e8
Upcoming events on Barinthus Biotherapeutics plc
Past events on Barinthus Biotherapeutics plc
| 20/03/2024 12:15 | Q4 2023 Earnings Release |
| 20/09/2023 19:00 | Investor Meeting - Key Opinion Leader |
| 11/09/2023 | H.C. Wainwright Global Investment Conference |
| 10/08/2023 13:00 | Q2 2023 Earnings Release |
| 20/06/2023 | European Association for the Study of the Liver Congress |
| 09/06/2023 17:45 | Jefferies Healthcare Conference |
| 01/06/2023 | American Society of Clinical Oncology Meeting |
| 22/05/2023 | A.G.P. Virtual Healthcare Conference |
| 12/05/2023 13:00 | Q1 2023 Earnings Release |
| 11/05/2023 13:00 | Annual General Meeting |
| 20/04/2023 19:00 | International Papillomavirus Conference |
| 24/03/2023 12:06 | Q4 2022 Earnings Release |
| 12/03/2023 | Oppenheimer Healthcare Conference |
| 08/01/2023 | J.P. Morgan Healthcare Conference |
| 01/12/2022 14:50 | Piper Sandler Healthcare Conference |
| 15/11/2022 17:35 | Jefferies London Healthcare Conference |
| 10/11/2022 21:30 | Q3 2022 Earnings Release |
| 07/11/2022 18:00 | American Association for the Study of Liver Disease Meeting - Abstract Number 38918 |
| 03/11/2022 | American Association for the Study of Liver Diseases Conference |
| 23/10/2022 | BIO-Europe Conference |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 4,82 | 0,27 0,59 -54.54% | 44,7 41,2 8.42% | 0,80 1,07 -24.85% | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -44,6 -36,3 -22.92% | 0,28 34,1 -99.17% | -78,5 -84,8 7.41% | -112 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -45,2 -51,1 11.57% | -4,04 5,75 -170.31% | -83,9 -87,1 3.63% | -102 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -51,1 -48,3 -5.97% | 0,85 7,77 -89.05% | -76,5 -81,3 5.86% | -100 |
|
Net income Million USD | Released Forecast Spread | 0,00 | -50,9 -46,8 -8.58% | 5,34 10,5 -49.2% | -73,3 -77,6 5.44% | -100 |
|
EPS USD | Released Forecast Spread | -692 | -1,96 -1,72 -13.84% | 0,14 0,26 -45.74% | -1,91 -1,96 2.65% | -2,17 |
| Announcement Date | 23/03/21 | 25/03/22 | 24/03/23 | 20/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,41 - | 15,0 3,71 305.34% | 17,1 3,71 360.54% | 6,17 8,00 -22.94% | 6,46 3,25 98.68% | 0,47 1,40 -66.57% | 0,33 0,60 -44.33% | 0,00 0,25 - | 0,00 0,13 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -16,7 -11,4 -46.73% | 0,65 -11,7 105.59% | 13,8 -14,7 193.62% | 7,55 -12,0 162.94% | -26,0 -16,3 -60.22% | -21,5 -22,0 2.35% | -26,3 -22,9 -15.01% | -16,1 -21,8 25.95% | -20,0 -22,6 11.69% | -24,6 | -24,8 | -25,3 | -25,4 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -15,1 -11,3 -33.66% | 1,71 -11,6 114.71% | 14,8 -14,7 200.77% | 7,55 -12,0 162.89% | -23,2 -16,3 -42.66% | -18,7 -22,0 14.82% | -25,0 -22,9 -9% | -14,7 -24,2 39.2% | -18,1 -22,0 17.85% | -24,6 | -24,8 | -25,3 | -25,4 | |
|
Net income Million USD | Released Forecast Spread | -15,1 -11,4 -33.04% | 2,60 -11,6 122.32% | 15,7 -14,7 207.03% | 8,24 -12,0 168.68% | -21,2 -16,3 -30.39% | -18,2 -22,0 17.36% | -23,8 -22,9 -3.94% | -14,1 -21,0 32.99% | -17,3 -21,5 19.49% | -24,6 | -24,8 | -25,3 | -25,4 | |
|
EPS USD | Released Forecast Spread | -0,38 -0,31 -23.38% | 0,07 -0,31 121.94% | 0,41 -0,32 226.84% | 0,22 -0,33 166.13% | -0,55 -0,22 -152.68% | -0,48 -0,58 17.24% | -0,62 -0,55 -13.35% | -0,37 -0,52 28.5% | -0,45 -0,48 6.59% | -0,54 | -0,54 | -0,53 | -0,56 | -0,71 |
| Announcement Date | 25/03/22 | 11/05/22 | 09/08/22 | 10/11/22 | 24/03/23 | 12/05/23 | 10/08/23 | 09/11/23 | 20/03/24 | - | - | - | - | - |
| 01/05/2024 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
| 01/05/2024 | CELLDEX THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | MIRUM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | RELAY THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | INTELLIA THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | GALAPAGOS NV: Q1 2024 Earnings Release |
| 02/05/2024 11:30 | MODERNA, INC.: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | BLUEPRINT MEDICINES CORPORATION: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | KYMERA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | IQVIA HOLDINGS INC.: Q1 2024 Earnings Release |
Past sector events for Barinthus Biotherapeutics plc
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- BRNS Stock
- Calendar Barinthus Biotherapeutics plc
